Ph.D., Senior Scientist, Sutter Health, California Pacific Medical Center (CPMC) Research Institute
Dr. Gregory Tranah is also an Adjunct Professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco. He received his PhD in Ecology from University of California, Davis and was a postdoctoral fellow in Epidemiology at the Harvard School of Public Health. Dr. Tranah’s current research program is focused on identifying inherited and acquired genetic factors that impact aging and disease with the goal of revolutionizing risk assessment and identifying widely applicable genomic tests that identify persons who would benefit from specific pharmacologic and behavioral treatments to prevent disability and disease. He is the principal investigator of several NIH grants and Sutter-CPMC Foundation grants. Dr. Tranah is the Genetics Director for several large population-based epidemiologic cohorts and is actively conducting large-scale genomic analyses in collaboration with several consortia focused on aging and disease. At the CPMC Research Institute he directs the genomics core of the Personalized Medicine program which is focused on identifying genomic predictors of treatment response for several highly malignant cancers. Dr. Tranah is currently leading a research program dedicated to accelerating the translation of research discoveries related to health and aging to clinical settings across Sutter Health and is applying this experience to the development of the Sutter Health Precision Medicine Program.
Precision Medicine: Making It Work on Scale
Sutter Precision Medicine program will be launching an integrated health system pipeline that simplifies and reduces the cost of banking patient biological samples and supports ready access to EHR and patient generated data to enhance identification of disease phenotypes and support partnerships to improve early detection of disease progression, treatment diagnostics, and development of new therapeutics.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Precision medicine is empowered by access to diverse data, patients, and provider networks. This session will describe the role of health systems as translational research partners that can drive: 1) molecular discoveries; 2) provider and patient engagement through an interoperable platform; and 3) rapid translation of discoveries to clinical practice.